Safety and Occupational Health Study Section: Notice of Charter Renewal, 42455 [2010-17759]

Download as PDF Federal Register / Vol. 75, No. 139 / Wednesday, July 21, 2010 / Notices or her records or otherwise provide enough information to enable the identification of the individual’s record; (3) identify the information that the individual believes is not accurate, relevant, timely or complete; (4) indicate what corrective action is sought; and (5) include supporting justification or documentation for the requested amendment. Verification of identity as described in the Department’s Privacy Act regulations may be required. 45 CFR 5b.5. RECORD SOURCE CATEGORIES: Information is obtained from individuals and organizations, including third parties conducting business on behalf of a business or organization, that apply for access privileges to the FPLS Child Support Services Portal and its services. Prevention, Department of Health and Human Services, has been renewed for a 2-year period through June 30, 2012. FOR FURTHER INFORMATION CONTACT: Price Connor, PhD, Executive Secretary, Safety and Occupational Health Study Section, Department of Health and Human Services, 1600 Clifton Road, NE., Mailstop E74, Atlanta, Georgia 30333, telephone 404/498–2511 or fax 404/498–2571. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: July 13, 2010. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. EXEMPTIONS CLAIMED FOR THE SYSTEM: None. [FR Doc. 2010–17738 Filed 7–20–10; 8:45 am] [FR Doc. 2010–17759 Filed 7–20–10; 8:45 am] BILLING CODE 4184–42–P BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Food and Drug Administration Safety and Occupational Health Study Section: Notice of Charter Renewal This gives notice under the Federal Advisory Committee Act (Pub. L. 92– 463) of October 6, 1972, that the Safety and Occupational Health Study Section, Centers for Disease Control and [Docket No. FDA–2010–N–0318] Novartis Pharmaceuticals Corp. et al.; Withdrawal of Approval of 27 New Drug Applications and 58 Abbreviated New Drug Applications AGENCY: ACTION: 42455 Notice. The Food and Drug Administration (FDA) is withdrawing approval of 27 new drug applications (NDAs) and 58 abbreviated new drug applications (ANDAs) from multiple applicants. The holders of the applications notified the agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn. SUMMARY: DATES: Effective Date: August 20, 2010. FOR FURTHER INFORMATION CONTACT: Florine P. Purdie, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 51, rm. 6366, Silver Spring, MD 20993–0002, 301– 796–3601. The holders of the applications listed in table 1 of this document have informed FDA that these drug products are no longer marketed and have requested that FDA withdraw approval of the applications pursuant to the process in § 314.150(c) (21 CFR 314.150(c)). The applicants have also, by their requests, waived their opportunity for a hearing. Withdrawal of approval of an application or abbreviated application under § 314.150(c) is without prejudice to refiling. SUPPLEMENTARY INFORMATION: Food and Drug Administration, HHS. TABLE 1. Application No. Drug Applicant Mesantoin (mephenytoin) Tablets Novartis Pharmaceuticals Corp., One Health Plaza, East Hanover, NJ 07936–1080 NDA 9–000 Cafergot (ergotamine tartrate and caffeine) Suppository, 1 milligram (mg)/100 mg and 2 mg/100 mg Do. NDA 9–561 Hypaque (diatrizoate sodium) GE Healthcare, Inc., 101 Carnegie Center, Princeton, NJ 08540 NDA 9–658 Hydrocortisone Tablets Smith, Miller and Patch, Inc., Division of Cooper Vision, Inc., c/o Cooper Laboratories, Inc., 455 E. Middlefied Rd., Mountain View, CA 94043 NDA 9–942 Deltra (prednisone) Tablets Merck & Co., Inc., P.O. Box 4, BLA–20, West Point, PA 19486–0004 NDA 10–051 erowe on DSKG8SOYB1PROD with NOTICES NDA 6–008 Hydeltra (prednisolone) Tablets Do. NDA 10–255 Meticortelone (prednisolone acetate) Injection and Suspension Schering Corp., Galloping Hill Rd., Kenilworth, NJ 07033 NDA 12–885 Winstrol (stanozolol) Tablets, 2 mg Lundbeck, Inc., Four Parkway North, Deerfield, IL 60015 NDA 13–428 Valpin (anisotropine methylbromide) Tablets Endo Pharmaceuticals, 100 Endo Blvd., Chadds Ford, PA 19317 VerDate Mar<15>2010 15:19 Jul 20, 2010 Jkt 220001 PO 00000 Frm 00082 Fmt 4703 Sfmt 4703 E:\FR\FM\21JYN1.SGM 21JYN1

Agencies

[Federal Register Volume 75, Number 139 (Wednesday, July 21, 2010)]
[Notices]
[Page 42455]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-17759]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Safety and Occupational Health Study Section: Notice of Charter 
Renewal

    This gives notice under the Federal Advisory Committee Act (Pub. L. 
92-463) of October 6, 1972, that the Safety and Occupational Health 
Study Section, Centers for Disease Control and Prevention, Department 
of Health and Human Services, has been renewed for a 2-year period 
through June 30, 2012.

FOR FURTHER INFORMATION CONTACT: Price Connor, PhD, Executive 
Secretary, Safety and Occupational Health Study Section, Department of 
Health and Human Services, 1600 Clifton Road, NE., Mailstop E74, 
Atlanta, Georgia 30333, telephone 404/498-2511 or fax 404/498-2571.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

    Dated: July 13, 2010.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2010-17759 Filed 7-20-10; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.